Ana Aleman

492 total citations
15 papers, 350 citations indexed

About

Ana Aleman is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Ana Aleman has authored 15 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Ana Aleman's work include Multiple Myeloma Research and Treatments (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Cancer therapeutics and mechanisms (3 papers). Ana Aleman is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Cancer therapeutics and mechanisms (3 papers). Ana Aleman collaborates with scholars based in United States. Ana Aleman's co-authors include Sergio Giralt, Richard E. Champlin, Donna Weber, Charles S. Cleeland, Michèle L. Donato, Rima M. Saliba, Chitra Hosing, J. Neumann, Nikhil Padhye and Marlene Z. Cohen and has published in prestigious journals such as Blood, Cancer and Gynecologic Oncology.

In The Last Decade

Ana Aleman

15 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Aleman United States	9	207	164	116	65	49	15	350
Aurélie Cabrespine France	10	122 0.6×	95 0.6×	60 0.5×	77 1.2×	18 0.4×	26	310
William R. Kiffmeyer United States	8	96 0.5×	75 0.5×	174 1.5×	141 2.2×	43 0.9×	9	446
Morgani Rodrigues Brazil	9	123 0.6×	44 0.3×	26 0.2×	23 0.4×	38 0.8×	32	225
Daniela Piccioni Italy	8	75 0.4×	64 0.4×	92 0.8×	29 0.4×	12 0.2×	22	221
Eleonora Biasin Italy	10	64 0.3×	41 0.3×	45 0.4×	53 0.8×	55 1.1×	20	226
Per Frisk Sweden	9	44 0.2×	47 0.3×	37 0.3×	77 1.2×	39 0.8×	27	221
Razelle Kurzrock United States	6	98 0.5×	141 0.9×	82 0.7×	40 0.6×	78 1.6×	7	403
Michele Pizzuti Italy	9	140 0.7×	108 0.7×	19 0.2×	27 0.4×	57 1.2×	15	333
R.B. Berryman United States	8	92 0.4×	104 0.6×	26 0.2×	8 0.1×	22 0.4×	16	237
Laura Peterson United States	9	27 0.1×	101 0.6×	42 0.4×	41 0.6×	53 1.1×	19	290

Countries citing papers authored by Ana Aleman

Since Specialization

Citations

This map shows the geographic impact of Ana Aleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Aleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Aleman more than expected).

Fields of papers citing papers by Ana Aleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Aleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Aleman. The network helps show where Ana Aleman may publish in the future.

Co-authorship network of co-authors of Ana Aleman

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Aleman. A scholar is included among the top collaborators of Ana Aleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Aleman. Ana Aleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cohen, Marlene Z., Cathy Rozmus, Tito R. Mendoza, et al.. (2012). Symptoms and Quality of Life in Diverse Patients Undergoing Hematopoietic Stem Cell Transplantation. Journal of Pain and Symptom Management. 44(2). 168–180. 84 indexed citations

Campagnaro, Erica, Rima M. Saliba, Sergio Giralt, et al.. (2008). Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer. 112(7). 1617–1624. 33 indexed citations

Christoforidou, Anna, Rima M. Saliba, Patricia Williams, et al.. (2007). Results of a Retrospective Single Institution Analysis of Targeted Skeletal Radiotherapy with 166Holmium-DOTMP as Conditioning Regimen for Autologous Stem Cell Transplant for Patients with Multiple Myeloma. Impact on Transplant Outcomes. Biology of Blood and Marrow Transplantation. 13(5). 543–549. 18 indexed citations

Oran, Betül, Michèle L. Donato, Ana Aleman, et al.. (2007). Transplant-Associated Microangiopathy in Patients Receiving Tacrolimus Following Allogeneic Stem Cell Transplantation: Risk Factors and Response to Treatment. Biology of Blood and Marrow Transplantation. 13(4). 469–477. 51 indexed citations

Qazilbash, Muzaffar H., Rima M. Saliba, Marcos de Lima, et al.. (2006). Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma. Cancer. 106(5). 1084–1089. 52 indexed citations

Qazilbash, Muzaffar H., Rima M. Saliba, Ana Aleman, et al.. (2006). Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma. Leukemia & lymphoma. 47(7). 1360–1364. 6 indexed citations

Qazilbash, Muzaffar H., Ana Aleman, Peter F. Thall, et al.. (2005). Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: A New Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.. Blood. 106(11). 1159–1159. 4 indexed citations

Christoforidou, Anna, Patricia Williams, Ana Aleman, et al.. (2005). Impact of Holmium-DOTMP on Transplant Outcomes. Results of a Retrospective Single Institution Analysis.. Blood. 106(11). 426–426. 1 indexed citations

Campagnaro, Erica, Rima M. Saliba, Karen O. Anderson, et al.. (2005). Risk Factors for Development of Symptoms Post Autologous Transplant for Multiple Myeloma.. Blood. 106(11). 1771–1771. 1 indexed citations

10.

Anagnostopoulos, Αchilles, Ana Aleman, Gregory D. Ayers, et al.. (2004). Comparison of high‐dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma. Cancer. 100(12). 2607–2612. 46 indexed citations

11.

Aleman, Ana, et al.. (2004). Nonmyeloablative reduced-intensity transplantation in multiple myeloma. Seminars in Oncology. 31(1). 33–36. 5 indexed citations

12.

Giralt, Sergio, Ana Aleman, M. Davis, et al.. (2004). Results of Bortezomib (BTZ) Therapy for Myeloma (MM) Patients Relapsing after an Allogeneic Transplant. Preliminary Results Show Efficacy without Induction of GVHD.. Blood. 104(11). 1651–1651. 4 indexed citations

13.

Donato, Michèle L., Ana Aleman, Richard E. Champlin, et al.. (2003). High-Dose Topotecan, Melphalan and Cyclophosphamide (TMC) with Stem Cell Support: a New Regimen for the Treatment of Multiple Myeloma. Leukemia & lymphoma. 45(4). 755–759. 20 indexed citations

14.

Anagnostopoulos, Athanasios K., Ana Aleman, & Sergio Giralt. (2003). Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: Review of the literature and future directions. Seminars in Oncology. 30(2). 286–290. 12 indexed citations

15.

Donato, Michele, David M. Gershenson, Cindy Ippoliti, et al.. (2001). High-Dose Topotecan, Melphalan, and Cyclophosphamide (TMC) with Stem Cell Support: A New Regimen for the Treatment of Advanced Ovarian Cancer. Gynecologic Oncology. 82(3). 420–426. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact